Food Safety Incidents

Non-Compliance With Food Safety Regulations And Standards has been detected in Nutritional Supplements.

Written by SGS Digicomply Editorial Team | Jul 29, 2025 10:00:00 PM

On July 28, 2025, the U.S. Food and Drug Administration reported an incident involving non-compliance with food safety regulations and standards related to nutritional supplements. This issue was identified within the United States of America, falling under the category of 'Other incident' and classified as 'Inadvertent Deviations.'

The findings indicate that certain nutritional supplements did not meet the established safety regulations, which are crucial for ensuring consumer protection and product integrity. Compliance with food safety standards is essential for maintaining trust and safety in dietary products, particularly those consumed by the public to support health and wellness.

The identification of these deviations highlights the importance of stringent oversight in the nutritional supplement industry. The U.S. Food and Drug Administration plays a critical role in monitoring compliance and addressing any discrepancies that may arise in the production and distribution of these products.

As this situation evolves, ongoing assessments and actions may be necessary to ensure that nutritional supplements adhere to the required safety regulations. Stakeholders in the industry are encouraged to remain vigilant regarding compliance to safeguard public health and welfare.

  • Incident: Non-Compliance With Food Safety Regulations And Standards has been detected in Nutritional Supplements.
  • Date: 2025-07-28
  • Product: Nutritional Supplements
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: United States of America
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Other incident
  • Hazard Category: Inadvertent Deviations
  • Source: U.S. Food and Drug Administration